NASDAQ · Drug Manufacturers - Specialty & Generic
BioCryst Pharmaceuticals Inc (BCRX)
$8.47
-0.59%
55
In band
Moving averages
SMA 200$8.71-2.76%
Company profile
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$2.11B
P/E ratioNone
EPS$-1.40
Beta0.548
Dividend yield0.00%
52-week high$11.22
52-week low$6.23
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 45
CGC
Canopy Growth Corporation
RSI 25
BFRI
Biofrontera Inc
RSI 42
TLRY
Tilray Brands Inc - Class 2
RSI 18
LNTH
Lantheus Holdings Inc
RSI 56
ACB
Aurora Cannabis Inc
RSI 50
ORGO
Organogenesis Holdings Inc - Class A
RSI 16
INM
InMed Pharmaceuticals Inc
RSI 71
RSI alerts for BCRX
An email when BCRX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:39 PM EDT